1. Home
  2. AMPH vs EXK Comparison

AMPH vs EXK Comparison

Compare AMPH & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • EXK
  • Stock Information
  • Founded
  • AMPH 1996
  • EXK 1981
  • Country
  • AMPH United States
  • EXK Canada
  • Employees
  • AMPH N/A
  • EXK N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • EXK Precious Metals
  • Sector
  • AMPH Health Care
  • EXK Basic Materials
  • Exchange
  • AMPH Nasdaq
  • EXK Nasdaq
  • Market Cap
  • AMPH 1.1B
  • EXK 949.5M
  • IPO Year
  • AMPH 2014
  • EXK N/A
  • Fundamental
  • Price
  • AMPH $23.71
  • EXK $4.80
  • Analyst Decision
  • AMPH Hold
  • EXK Strong Buy
  • Analyst Count
  • AMPH 5
  • EXK 3
  • Target Price
  • AMPH $38.00
  • EXK $6.83
  • AVG Volume (30 Days)
  • AMPH 466.2K
  • EXK 17.9M
  • Earning Date
  • AMPH 08-06-2025
  • EXK 07-31-2025
  • Dividend Yield
  • AMPH N/A
  • EXK N/A
  • EPS Growth
  • AMPH N/A
  • EXK N/A
  • EPS
  • AMPH 2.77
  • EXK N/A
  • Revenue
  • AMPH $730,659,000.00
  • EXK $217,412,000.00
  • Revenue This Year
  • AMPH $0.67
  • EXK $99.18
  • Revenue Next Year
  • AMPH $5.18
  • EXK $49.21
  • P/E Ratio
  • AMPH $8.48
  • EXK N/A
  • Revenue Growth
  • AMPH 8.05
  • EXK 1.72
  • 52 Week Low
  • AMPH $22.64
  • EXK $2.46
  • 52 Week High
  • AMPH $53.96
  • EXK $5.67
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.92
  • EXK 63.14
  • Support Level
  • AMPH $24.35
  • EXK $4.53
  • Resistance Level
  • AMPH $25.04
  • EXK $5.07
  • Average True Range (ATR)
  • AMPH 0.66
  • EXK 0.24
  • MACD
  • AMPH -0.22
  • EXK -0.02
  • Stochastic Oscillator
  • AMPH 7.55
  • EXK 60.63

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

Share on Social Networks: